The forecast of a cancer patient is significantly improved if the disease is diagnosed at an early stage. However, existing techniques are invasive, expensive, the results aren't immediate (creating psychological burden), and tumors are often detected at an advanced stage due to the asymptomatic beginning of the disease. At PGM NanoSensing we're committed to develop a product that will overcome all the aforementioned disadvantages.